Showing results (151-160 of 188) with videos related to

Sort By:
Pageof 19
Muscle & Nerve|January 1, 1997
Evaluation of neuropathy in patients on suramin treatmentB Soliven, U K Dhand, K Kobayashi, et al.
Blood|March 1, 1987
Durability of responses to interferon alfa-2b in advanced hairy cell leukemiaM J Ratain, H M Golomb, R G Bardawil, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Phase I study of ZD9331 on short daily intravenous bolus infusion for 5 days every 3 weeks with fixed dosing recommendationsB C Goh, M J Ratain, D Bertucci, et al.
European Journal of Cancer (Oxford, England : 1990)|March 29, 2011
A phase I study of sirolimus and bevacizumab in patients with advanced malignanciesE E W Cohen, M R Sharma, L Janisch, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 13, 2001
Elimination pathways of [14C]losoxantrone in four cancer patientsA S Joshi, H J Pieniaszek, E E Vokes, et al.
Journal of the National Cancer Institute|August 18, 1993
Phase I trial of granulocyte-macrophage colony-stimulating factor plus high-dose cyclophosphamide given every 2 weeks: a Cancer and Leukemia Group B studyS M Lichtman, M J Ratain, D A Van Echo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2004
A phase I study of the oral combination of CI-994, a putative histone deacetylase inhibitor, and capecitabineS D Undevia, H L Kindler, L Janisch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Pharmacodynamics of fluorouracil-based induction chemotherapy in advanced head and neck cancerE E Vokes, R Mick, M S Kies, et al.
The Pharmacogenomics Journal|July 2, 2014
Establishment of CYP2D6 reference samples by multiple validated genotyping platformsH Fang, X Liu, J Ramírez, et al.
Journal of the National Cancer Institute|February 19, 1997
Thymidylate synthase expression and response to neoadjuvant chemotherapy in patients with advanced head and neck cancerP G Johnston, R Mick, W Recant, et al.
Pageof 19